Human Trials to Begin for Moderna’s HIV Vaccine
Biotech company Moderna may begin human trials this week for two mRNA-based HIV vaccines, according to the National Institutes of Health’s clinical trial registry.
Biotech company Moderna may begin human trials this week for two mRNA-based HIV vaccines, according to the National Institutes of Health’s clinical trial registry.